Concepedia

Author

Jürgen Finke

University of FreiburgORCID

Also Known As

E. Moser, Finke, J, Finke, J., Finke, Juergen, Finke, Jürgen, J FINKE, J Finke, J. Finke, J. Snowden, J. finke

877

Publications

30.3K

Citations

87

H-Index

134

Concepts

All Affiliations

University of FreiburgUniversity Medical Center FreiburgUniversität HamburgUniversity Medical Center Hamburg-EppendorfSorbonne Université
JF

About

Jürgen Finke is an author at University of Freiburg specializing in medicine, transplantation, and cell transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

59

158

12.2K

2

Health Sciences

30

56

2.5K

3

Biomedical Engineering

2

2

49

4

Engineering

1

1

208

5

Allergy

1

1

26

Jürgen Finke

×

344

Publications

26.9K

Citations

82

H-Index

YearCitations

Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

Vanderson Rocha, Myriam Labopin, Guillermo Sanz,

New England Journal of Medicine

2004

1.1K

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

Jürgen Finke, Wolfgang Bethge, Claudia Schmoor,

The Lancet Oncology

2009

705

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski,

The Lancet Haematology

2016

582

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease

Nicolaus Kröger, Carlos Solano, Christine Wolschke,

New England Journal of Medicine

2016

541

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>–Internal Tandem Duplication Mutation (SORMAIN)

Andreas Burchert, Gesine Bug, Lea Fritz,

Journal of Clinical Oncology

2020

538

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Robert Zeiser, Andreas Burchert, Claudia Lengerke,

Leukemia

2015

535

Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

Christoph Schmid, Myriam Labopin, Arnon Nagler,

Journal of Clinical Oncology

2007

513

Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinoma

Hu Li Fu, Ingemar Ernberg, Jürgen Finke,

International Journal of Cancer

1988

443

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R

Konrad Wilhelm, Jayanthi Ganesan, Tobias Müller,

Nature Medicine

2010

424

Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

Cristina Toffalori, Laura Zito, Valentina Gambacorta,

Nature Medicine

2019

393

Page 1